Johnson & Johnson Development Corporation, the in-house venture arm of the US-based consumer and medical goods maker, has linked up again with venture capital firm De Novo Ventures and joined the second round of financing for Astute Medical, a San Diego-based medical diagnostics company focused on high-risk conditions.
Astute raised $26.5m in series B funding in a round led by VCs Domain Associates and Delphi Ventures. JJDC joined for the first time while De Novo returned having previously invested…
